| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 09/20/2005 | US6946149 Salt solution for colon cleansing |
| 09/20/2005 | US6946135 Prevention and treatment of amyloidogenic disease |
| 09/20/2005 | US6945247 Method of treating cardio pulmonary diseases with no group compounds |
| 09/15/2005 | WO2005085254A1 Process for inhibiting cell proliferation |
| 09/15/2005 | WO2005084786A1 Water containing oxygen nano bubbles and method for production thereof |
| 09/15/2005 | WO2005084690A1 Use of enhanced water to improve blood sugar management |
| 09/15/2005 | WO2005084619A1 Composition comprising sodium silicate for use in the treatment of dry skin conditions |
| 09/15/2005 | WO2005084462A2 Nanoscale and supersaturated solutions of mineral or trace elements and a method for production of nanoparticles mixtures of nanoparticles, nanoscale solutions and general supersaturated solutions |
| 09/15/2005 | WO2005013951A3 Pharmaceutical compositions for preventing breast and ovarian cancer |
| 09/15/2005 | WO2005000210A3 Synthesis of high molecular weight iron-saccharidic complexes |
| 09/15/2005 | WO2004093793A3 Delivery vehicle for silver ions |
| 09/15/2005 | WO2004078654A3 Free radical solution water |
| 09/15/2005 | US20050202103 For treatment of obesity, reduction of blood glucose and blood pressure; sexual disorders |
| 09/15/2005 | US20050202101 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 09/15/2005 | US20050202099 Copper alloy substrate with film comprising protective layer (formed of nitrides, carbides) with anti-microbial metal particles dispersed therein; sputtering; corrosion resistance; wear resistance |
| 09/15/2005 | US20050202085 Enclosing a unit dose of aspirin in an enclosure having indications and a twist off cap, and a nutritional supplement of calcium |
| 09/15/2005 | US20050201989 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitors of tumor necrosis factor-alpha |
| 09/15/2005 | US20050201976 Selective inhibitors of nuclear factor-kappaB activation and uses thereof |
| 09/15/2005 | US20050201940 Diagnostics and radiotherapy; magnetic resonance imaging (MRI); treatment of a tumor |
| 09/15/2005 | CA2558715A1 Process for inhibiting cell proliferation |
| 09/15/2005 | CA2558183A1 Use of enhanced water to improve blood sugar management |
| 09/14/2005 | EP1574207A1 Cosmetic use of viscous compositions containing carbon dioxide |
| 09/14/2005 | EP1574132A2 Antimicrobial sanitary ware and method for making the same |
| 09/14/2005 | EP1572897A2 Ordered biological nanostructures formed from chaperonin polypeptides |
| 09/14/2005 | EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 09/14/2005 | EP1572182A1 Composition for the treatment of gastrointestinal disorders |
| 09/14/2005 | EP1571904A2 Ionic plasma deposition of anti-microbial surfaces and the anti-microbial surfaces resulting therefrom |
| 09/14/2005 | EP1274445B1 Use of steroidal alkaloids to reverse multidrug resistance |
| 09/14/2005 | EP1001793B1 Chromium/biotin treatment of type ii diabetes |
| 09/14/2005 | CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/14/2005 | CN1668580A Aminoacetonitriles derivant for controlling parasite |
| 09/14/2005 | CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 09/14/2005 | CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 09/14/2005 | CN1668320A Tablet composition containing chinese orthodox medicine extract and process for producing the same |
| 09/14/2005 | CN1668316A Anti-spasmodic comprising xenon |
| 09/14/2005 | CN1668315A Anti-spasmodic comprising xenon |
| 09/14/2005 | CN1668314A Methods of treating hepatitis |
| 09/14/2005 | CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea |
| 09/14/2005 | CN1218882C Ferric oxide with high magnetic-hysteresis heat generation ability for the use of tumour thermomagnetic therapy and method for preparing the same |
| 09/14/2005 | CN1218744C Preparing method of burn and scald treating medicine |
| 09/14/2005 | CN1218734C Health products for improving functions of stomach intestine |
| 09/14/2005 | CN1218732C Preparation process of Qingkailing injection and injection powder |
| 09/14/2005 | CN1218729C Xuerongguyugao ointment for healing fracture and its prepn. |
| 09/14/2005 | CN1218728C Chinese traditional medicine composition for treating epilepsy |
| 09/14/2005 | CN1218727C Traditional Chinese medicine composition for cancer |
| 09/14/2005 | CN1218726C Heat-clearing and stagnation-dissipating particle medicine and preparation method thereof |
| 09/14/2005 | CN1218716C Medicine for treating toxuria, and its prepn. method |
| 09/14/2005 | CN1218715C Bone-setting silky fowl ointment for treating osteological diseases and its preparation and application |
| 09/14/2005 | CN1218705C Anti SARS virus medicine and synthesizing method thereof |
| 09/14/2005 | CN1218685C Meerschaum toothpaste and preparation process thereof |
| 09/14/2005 | CN1218669C Toxin-reducing dehabit preparation of cigarette with health-care function |
| 09/13/2005 | US6943197 Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses |
| 09/13/2005 | US6943155 Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity |
| 09/13/2005 | CA2370920C Feedstock for prepartum dairy cattle |
| 09/09/2005 | WO2005082393A1 Stabilized feverfew formulations |
| 09/09/2005 | WO2005082386A2 Manganese and iron based compounds for elastogenesis and connective tissue treatment |
| 09/09/2005 | WO2005082385A1 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
| 09/09/2005 | WO2005082384A1 Artificial physiological salt solution and process for producing the same |
| 09/09/2005 | WO2005082383A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/09/2005 | WO2005082382A1 Formulations of thiomolybdate or thiotungstate compounds and uses thereof |
| 09/09/2005 | WO2005082071A2 Antimicrobial food additive and treatment for cooked food, water and wastewater |
| 09/09/2005 | WO2005082069A2 Hangover remedy and alcohol abatement composition |
| 09/09/2005 | WO2005072712A3 Antimicrobial composition |
| 09/09/2005 | WO2005060976A3 Use of superoxide dismutase mimetics and reductase glutathione in the form of anticancer drugs |
| 09/09/2005 | WO2005046708A8 Selective inhibitors of nuclear factor-kb activation and uses thereof |
| 09/09/2005 | WO2005027834A3 Partially hydrated hemostatic agent |
| 09/09/2005 | WO2005016271A3 Composition comprising a zeolite compound for treatment of diseases |
| 09/09/2005 | CA2846382A1 Iron based compounds for elastogenesis and connective tissue treatment |
| 09/09/2005 | CA2599366A1 Antimicrobial food additive and treatment for cooked food, water and wastewater |
| 09/09/2005 | CA2599362A1 Hangover remedy and alcohol abatement composition |
| 09/09/2005 | CA2562871A1 Iron based compounds for elastogenesis and connective tissue treatment |
| 09/09/2005 | CA2557531A1 Artificial physiological salt solution and manufacturing method for same |
| 09/09/2005 | CA2548771A1 A medical solution, a method for producing said medical solution and use thereof |
| 09/08/2005 | US20050197282 Compositions and methods for treatment of psoriasis |
| 09/08/2005 | US20050196793 Using aberrant expression of caudal type homeobox transcription factor 2 (CDX2) as diagnostic indicator of stomach or esophageal cell proliferative disorers |
| 09/08/2005 | US20050196469 Calcium in the form of a carbonate, citrate, citrate malate, gluconate, lactate, acetate, or stearate salt, vitamin D3, and folic acid or folinic acid; multi-vitamins |
| 09/08/2005 | US20050196468 Composition and method for nutritional supplement for drug abuse treatment and rehabilitation |
| 09/08/2005 | US20050196467 Treatment system including carotenoid, nicotinamide, zinc, water soluble extract of uncaria species and deterium reduced aqueous fluid and method using the same |
| 09/08/2005 | US20050196466 Process for inhibiting cell proliferation |
| 09/08/2005 | US20050196465 Hangover relief composition |
| 09/08/2005 | US20050196464 Method and pharmaceutical composition for treatment of skin neoplasm |
| 09/08/2005 | US20050196463 NO-containing complexes |
| 09/08/2005 | US20050196462 Topical formulation containing oxidative reductive potential water solution and method for using same |
| 09/08/2005 | US20050196456 Controlled release particles |
| 09/08/2005 | US20050196434 Pharmaceutical composition and method for the transdermal delivery of magnesium |
| 09/08/2005 | US20050196433 Delivery mechanism for magnesium which alleviates the disadvantages associated with the oral administration of magnesium supplements; magnesium chloride, zinc chloride, pluronic lecithin organogel, vitamin B6; diabetes, hypertension, high cholesterol, cardiac arrhythmias, acute myocardial infarction |
| 09/08/2005 | US20050196430 For imparting built-in and long lasting antimicrobial characteristics to ceramic products such as toilets, bidets, washbasins, towel rails, soap holders, toilet roll holders, water control fixtures, and ceramic tiles |
| 09/08/2005 | US20050196399 antibody capable of specifically recognizing two regions of the A4 peptide/A beta 4, wherein the first region comprises the amino acid sequence AEFRHDSGY and the second region comprises the amino acid sequence YEVHHQKLVFFAEDVG |
| 09/08/2005 | US20050196374 Defecation deodorant |
| 09/08/2005 | DE60110057T2 Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung Liposomes containing an entrapped compound in solution übersattigter |
| 09/07/2005 | EP1570852A2 Xenon for use as drug |
| 09/07/2005 | EP1570751A1 Composition for the activation of the immune system |
| 09/07/2005 | EP1569665A2 Composition and method for mammary disinfection during winter conditions |
| 09/07/2005 | EP1569528A1 Methods of using a beverage composition |
| 09/07/2005 | EP1511457A4 A composition and method for inhibiting polar capsule discharge and protecting a subject from nematocyst sting |
| 09/07/2005 | EP1235582A4 Methods and kits for use in preventing restenosis |
| 09/07/2005 | CN1665933A Immunoconjugates for the treatment of tumours |
| 09/07/2005 | CN1665566A Methods and compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium c |
| 09/07/2005 | CN1665542A Adjuvant containing xenon |
| 09/07/2005 | CN1665519A Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |